CLN-049 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)
CLN-049 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)
Recruiting · NCT05143996 · Registry updated 2026-01-16Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| CLN-049 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS) | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, bone marrow disorder, hematologic disorder, leukemia, myelodysplastic syndrome, myeloid leukemia, neoplasm | Recruiting | Phase 1 | 2026-01-16 | NCT05143996 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Cullinan Therapeutics Inc. | 10 |
11 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Cincinnati Children's Hospital Medical Center | Cincinnati | United States | 405 |
| Duke Cancer Center | Durham | United States | 44 |
| Emory University Hospital | Atlanta | United States | 131 |
| Massachusetts General Hospital | Boston | United States | 1015 |
| MD Anderson | Houston | United States | 56 |
| Moffitt Cancer Center | Tampa | United States | 523 |
| New York University | New York | United States | 26 |
| Roswell Park Cancer Institute | Buffalo | United States | 382 |
| UCLA | Los Angeles | United States | 80 |
| University of Alabama O'Neal Cancer Center | Birmingham | United States | 1 |
| University of Miami Health System | Miami | United States | 13 |